Related Experiment Video
Updated: Oct 13, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using
Zhiying Yin1, Canjie Zheng1, Quanjun Fang1
1Quzhou Center for Disease Control and Prevention, Quzhou, 324000 Zhejiang, China.
Abstract:
Mumps is a vaccine-preventable disease caused by the mumps virus, but the incidence of mumps has increased among the children who were vaccinated with one-dose measles-mumps-rubella (MMR) in recent years. In this study, we analyzed the influence of different doses of mumps-containing vaccine (MuCV) against mumps using Cox-proportional hazard model. We collected 909 mumps cases of children who were born from 2006 to 2010 and vaccinated with different doses of MuCV in Quzhou during 2006-2018, which were all clinically diagnosed. Kaplan-Meier survival methods and Cox-proportional hazard model were used to estimate the hazard probabilities. Kaplan-Meier curves showed that the cumulative hazard of male and female has no difference; lower hazards were detected among those who were vaccinated with two-dose MuCV, born in 2006, and infected after supplementary immunization activities (SIA). Cox-proportional hazard regression suggested that onset after SIA, born in 2006, and vaccinated with two-dose MuCV were protective factors against infection even after adjusting for potential confounding effects. Our study showed that it was necessary to revise the diagnostic criteria of mumps and identify RT-PCR as the standard for mumps diagnosis in China. We suggested that routine immunization schedule should introduce two doses of MMR and prevaccination screening should be performed before booster immunization in vaccinated populations.
Insights
Two doses of the measles-mumps-rubella (MMR) vaccine offer better protection against mumps than one dose. This study suggests revising diagnostic criteria and implementing two-dose MMR vaccination for improved mumps control.
Area of Science:
- Epidemiology
- Vaccinology
- Virology
Background:
- Mumps incidence is rising in vaccinated children, indicating waning immunity or vaccine effectiveness issues.
- The measles-mumps-rubella (MMR) vaccine is crucial for mumps prevention, but one-dose efficacy is questioned.
- Understanding the impact of different mumps-containing vaccine (MuCV) doses is vital for public health strategies.
Purpose of the Study:
- To analyze the effectiveness of varying mumps-containing vaccine (MuCV) doses against mumps.
- To identify risk factors and protective factors for mumps infection in vaccinated children.
- To inform recommendations for mumps vaccination schedules and diagnostic criteria in China.
Main Methods:
- Retrospective analysis of 909 clinically diagnosed mumps cases in children vaccinated with different MuCV doses.
- Application of Kaplan-Meier survival analysis and Cox-proportional hazard models.
- Inclusion of data from children born between 2006-2010, vaccinated in Quzhou (2006-2018).
Main Results:
- Kaplan-Meier curves showed no significant difference in cumulative hazard between males and females.
- Lower mumps hazard was observed in children vaccinated with two-dose MuCV, born in 2006, and infected after supplementary immunization activities (SIA).
- Cox regression confirmed that onset after SIA, birth year 2006, and two-dose MuCV vaccination were protective factors against mumps.
Conclusions:
- The study highlights the need for revised mumps diagnostic criteria, recommending RT-PCR as the standard in China.
- A two-dose MMR vaccination schedule is suggested for routine immunization.
- Prevaccination screening before booster immunizations in vaccinated populations is recommended to enhance mumps control.
More Related Videos
Related Concept Videos
Vaccinations
Hazard Ratio
For example, in a clinical trial...
Relative Risk
Statistical Methods for Analyzing Epidemiological Data
Dosage Regimen Designs: Nomograms and Tabulations
Principles of Disease Surveillance

